Consultation closed

Proposed update to document on Post-Market Clinical Follow-Up Studies

Start date
Closing date
Working group
Medical Device Clinical Evaluation

A Proposed Document on Post-Market Clinical Follow-up Studies has been released by the International Medical Device Regulators Forum (IMDRF) Medical Devices Clinical Evaluation Working Group.

Thank you for your contribution aiming at the validation of the IMDRF document.

Consultation documents

Post-Market Clinical Follow-up Studies - IMDRF MDCE WG(PD1)/Nx (formerly GHTF/SG5/N4:2010)

Please use the comments template to provide comments on the Proposed Document and email comments to liuyh [at] cmde.org.cn (liuyh[at]cmde[dot]org[dot]cn).

Comments Template - IMDRF MDCE WG (WD) Nx (formerly GHTF/SG5/N4:2010) Post-Market Clinical Follow-up Studies

Member sites

Regional harmonization initiatives

APEC LSIF Regulatory Harmonization Steering Committee

Pan American Health Organization (PAHO)

African Medical Devices Forum (AMDF)

Official observers

Argentina, National Administration of Drugs, Food and Medical Devices

The World Health Organization (WHO)

Saudi Arabia, Saudi Food and Drug Authority

Affiliate members

Botswana - Botswana Medicines Regulatory Authority (BoMRA)

Chile - Public Health Institute of Chile (ISP)

Chinese Taipei Taiwan Food and Drug Administration (TFDA)

Costa Rica - Ministry of Health

Cuba - Centro para el Control Estatal de Medicamentos, Equipos y Dispositivos Médicos (CECMED)

Dominican Republic - General Directorate of Medicines, Food and Health Products (DIGEMAPS)

Egypt - Egyptian Drug Authority  (EDA)

El Salvador - Sanitary Regulation Superintendency (SRS)

Ethiopia - Ethiopian Food and Drug Authority (EFDA)

India - Central Drugs Standard Control Organization (CDSCO)

Israel - The Medical Technology, Health Information, Innovation and Research Directorate (MTIIR)

Affiliates

 

Jordan - Jordan Food and Drug Administration (JFDA)

Kenya - Pharmacy and Poisons Board (PPB)

Malaysia - Medical Device Authority (MDA)

Mexico - Federal Commission for Protection from Sanitary Risks (COFEPRIS)

Montenegro - Institute for Medicine and Medical Devices of Montenegro (CINMED)

Nigeria - National Agency for Food and Drug Administration Control (NAFDAC)

Oman - Drug Safety Center, Medical Device Control Department (DSC)

Paraguay - National Health Surveillance (DINAVISA)

Peru - General Directorate of Medicines, Supplies and Drugs (DIGEMID)

South Africa - South African Health Products Regulatory Authority (SAHPRA)

Tanzania - Tanzania Medicines and Medical Devices Authority (TMDA)

Uzbekistan - The Center for Pharmaceutical Products Safety

Zanzibar - Zanzibar Food and Drug Agency (ZFDA)

Zimbabwe - Medicines Control Authority (MCAZ)